Cytokinetics
CYTK
#2450
Rank
NZ$12.78 B
Marketcap
NZ$104.53
Share price
-0.65%
Change (1 day)
36.61%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2025 (TTM): -NZ$1.3 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are NZ$87.21 Million. In 2024 the company made an earning of -NZ$1 Billion a decrease over its 2023 earnings that were of -NZ$0.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$1.3 Billion31.2%
2024 -NZ$1 Billion12.03%
2023 -NZ$0.89 Billion35.3%
2022 -NZ$0.66 Billion80.65%
2021 -NZ$0.37 Billion69.15%
2020 -NZ$0.22 Billion4.6%
2019 -NZ$0.21 Billion14.49%
2018 -NZ$0.18 Billion-16.83%
2017 -NZ$0.22 Billion-812.8%
2016 NZ$30.11 M-147.81%
2015 -NZ$63.01 Million156.05%
2014 -NZ$24.61 Million-56.56%
2013 -NZ$56.65 Million-16.48%
2012 -NZ$67.83 Million-15.65%
2011 -NZ$80.41 Million-3.24%
2010 -NZ$83.1 Million-308.68%
2009 NZ$39.82 M-141.87%
2008 -NZ$95.1 Million0.21%
2007 -NZ$94.9 Million-7.91%
2006 -NZ$0.11 Billion37.42%
2005 -NZ$74.99 Million16.13%
2004 -NZ$64.57 Million-19.29%
2003 -NZ$80 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$13.84 B-1,196.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-NZ$52.18 Million-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-108.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.46 Billion-63.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ$7.4 M-100.59%๐Ÿ‡บ๐Ÿ‡ธ USA